Literature DB >> 15924415

Interaction between TFF1, a gastric tumor suppressor trefoil protein, and TFIZ1, a brichos domain-containing protein with homology to SP-C.

Bruce R Westley1, S Michael Griffin, Felicity E B May.   

Abstract

TFF1 is a gastric tumor suppressor that protects gastric epithelial cells from damage but can promote invasive properties of tumor cells. Antibodies were raised against correctly folded TFF1 protein. These showed that the 6.67 kDa secreted trefoil protein is present as an approximately 25 kDa complex in normal human gastric mucosa. The TFF1 complex was immunopurified from human gastric mucosa and shown to comprise two proteins joined by a disulfide bond. Both were identified by amino-terminal sequencing and MALDI TOF mass spectrometry. The TFF1 protein partner is a previously unknown protein that we have called TFIZ1 for trefoil factor interactions(z) 1. TFIZ1 is expressed and secreted in normal gastric mucosa. TFIZ1 mRNA was cloned from gastric mucosa and sequenced. TFIZ1 is an 18.31 kDa protein and contains an approximately 100 amino acid brichos domain and homology with smart00019.10, SF_P. This is the first demonstration that a member of the trefoil factor family of proteins is bound covalently to a brichos domain-containing protein. The apparent molecular mass of the TFF1:TFIZ1 heterodimer is remarkably close to the theoretical molecular mass of 24.98 kDa. In conclusion, the heterodimer comprises one molecule each of TFF1 and TFIZ1, and the disulfide bond between TFF1 and TFIZ1 is the most important factor stabilizing the heterodimer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15924415     DOI: 10.1021/bi047287n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  41 in total

1.  Trefoil factor family peptide 2 acts pro-proliferative and pro-apoptotic in the murine retina.

Authors:  Adnana N Paunel-Görgülü; Andreas G Franke; Friedrich P Paulsen; Nicole Dünker
Journal:  Histochem Cell Biol       Date:  2011-04-22       Impact factor: 4.304

Review 2.  Trefoils: An unexplored natural protective shield of oral cavity.

Authors:  Akanksha Choudhary; C N Smitha; D K Suresh
Journal:  J Oral Biol Craniofac Res       Date:  2015-07-29

3.  Loss of TFF1 is associated with activation of NF-κB-mediated inflammation and gastric neoplasia in mice and humans.

Authors:  Mohammed Soutto; Abbes Belkhiri; M Blanca Piazuelo; Barbara G Schneider; Dunfa Peng; Aixiang Jiang; M Kay Washington; Yasin Kokoye; Sheila E Crowe; Alexander Zaika; Pelayo Correa; Richard M Peek; Wael El-Rifai
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

4.  Heterodimeric interaction between GKN2 and TFF1 entails synergistic antiproliferative and pro-apoptotic effects on gastric cancer cells.

Authors:  Olga Kim; Jung Hwan Yoon; Won Suk Choi; Hassan Ashktorab; Duane T Smoot; Suk Woo Nam; Jung Young Lee; Won Sang Park
Journal:  Gastric Cancer       Date:  2017-02-01       Impact factor: 7.370

5.  Gastrokine-2 is downregulated in gastric cancer and its restoration suppresses gastric tumorigenesis and cancer metastasis.

Authors:  Jin Dai; Ning Zhang; Jinhui Wang; Minhu Chen; Jie Chen
Journal:  Tumour Biol       Date:  2014-01-10

6.  Gastrointestinal tract specific gene GDDR inhibits the progression of gastric cancer in a TFF1 dependent manner.

Authors:  Guanghui Chu; Shengbin Qi; Guodong Yang; Kefeng Dou; Jianjun Du; Zifan Lu
Journal:  Mol Cell Biochem       Date:  2011-08-26       Impact factor: 3.396

7.  Global analysis of the human gastric epithelial transcriptome altered by Helicobacter pylori eradication in vivo.

Authors:  M B Resnick; E Sabo; P A Meitner; S S Kim; Y Cho; H K Kim; R Tavares; S F Moss
Journal:  Gut       Date:  2006-04-26       Impact factor: 23.059

8.  Proteolytic effects of gingipains on trefoil factor family peptides.

Authors:  Ponlatham Chaiyarit; Janthima Jaresitthikunchai; Narumon Phaonakrop; Sittiruk Roytrakul; Barbara Potempa; Jan Potempa
Journal:  Clin Oral Investig       Date:  2017-07-19       Impact factor: 3.573

9.  Evolution of the human gastrokine locus and confounding factors regarding the pseudogenicity of GKN3.

Authors:  Jessica H Geahlen; Carlo Lapid; Kaisa Thorell; Igor Nikolskiy; Won Jae Huh; Edward L Oates; Jochen K M Lennerz; Xiaolin Tian; Victoria G Weis; Shradha S Khurana; Samuel B Lundin; Alan R Templeton; Jason C Mills
Journal:  Physiol Genomics       Date:  2013-05-28       Impact factor: 3.107

10.  Loss of gastrokine-2 drives premalignant gastric inflammation and tumor progression.

Authors:  Trevelyan R Menheniott; Louise O'Connor; Yok Teng Chionh; Jan Däbritz; Michelle Scurr; Benjamin N Rollo; Garrett Z Ng; Shelley Jacobs; Angelique Catubig; Bayzar Kurklu; Stephen Mercer; Toshinari Minamoto; David E Ong; Richard L Ferrero; James G Fox; Timothy C Wang; Philip Sutton; Louise M Judd; Andrew S Giraud
Journal:  J Clin Invest       Date:  2016-03-14       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.